Hypersomnia Drug Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypersomnia Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Provigil
1.2.3 Xyrem
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hypersomnia Drug Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hypersomnia Drug Market Perspective (2018-2029)
2.2 Hypersomnia Drug Growth Trends by Region
2.2.1 Hypersomnia Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hypersomnia Drug Historic Market Size by Region (2018-2023)
2.2.3 Hypersomnia Drug Forecasted Market Size by Region (2024-2029)
2.3 Hypersomnia Drug Market Dynamics
2.3.1 Hypersomnia Drug Industry Trends
2.3.2 Hypersomnia Drug Market Drivers
2.3.3 Hypersomnia Drug Market Challenges
2.3.4 Hypersomnia Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypersomnia Drug Players by Revenue
3.1.1 Global Top Hypersomnia Drug Players by Revenue (2018-2023)
3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2018-2023)
3.2 Global Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hypersomnia Drug Revenue
3.4 Global Hypersomnia Drug Market Concentration Ratio
3.4.1 Global Hypersomnia Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypersomnia Drug Revenue in 2022
3.5 Hypersomnia Drug Key Players Head office and Area Served
3.6 Key Players Hypersomnia Drug Product Solution and Service
3.7 Date of Enter into Hypersomnia Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypersomnia Drug Breakdown Data by Type
4.1 Global Hypersomnia Drug Historic Market Size by Type (2018-2023)
4.2 Global Hypersomnia Drug Forecasted Market Size by Type (2024-2029)
5 Hypersomnia Drug Breakdown Data by Application
5.1 Global Hypersomnia Drug Historic Market Size by Application (2018-2023)
5.2 Global Hypersomnia Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hypersomnia Drug Market Size (2018-2029)
6.2 North America Hypersomnia Drug Market Size by Country (2018-2023)
6.3 North America Hypersomnia Drug Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hypersomnia Drug Market Size (2018-2029)
7.2 Europe Hypersomnia Drug Market Size by Country (2018-2023)
7.3 Europe Hypersomnia Drug Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hypersomnia Drug Market Size (2018-2029)
8.2 Asia-Pacific Hypersomnia Drug Market Size by Country (2018-2023)
8.3 Asia-Pacific Hypersomnia Drug Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hypersomnia Drug Market Size (2018-2029)
9.2 Latin America Hypersomnia Drug Market Size by Country (2018-2023)
9.3 Latin America Hypersomnia Drug Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypersomnia Drug Market Size (2018-2029)
10.2 Middle East & Africa Hypersomnia Drug Market Size by Country (2018-2023)
10.3 Middle East & Africa Hypersomnia Drug Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Hypersomnia Drug Introduction
11.1.4 Teva Revenue in Hypersomnia Drug Business (2018-2023)
11.1.5 Teva Recent Development
11.2 Jazz Pharmaceuticals
11.2.1 Jazz Pharmaceuticals Company Detail
11.2.2 Jazz Pharmaceuticals Business Overview
11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Introduction
11.2.4 Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2018-2023)
11.2.5 Jazz Pharmaceuticals Recent Development
11.3 BIOPROJET
11.3.1 BIOPROJET Company Detail
11.3.2 BIOPROJET Business Overview
11.3.3 BIOPROJET Hypersomnia Drug Introduction
11.3.4 BIOPROJET Revenue in Hypersomnia Drug Business (2018-2023)
11.3.5 BIOPROJET Recent Development
11.4 AVADEL PHARMACEUTICALS
11.4.1 AVADEL PHARMACEUTICALS Company Detail
11.4.2 AVADEL PHARMACEUTICALS Business Overview
11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Introduction
11.4.4 AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2018-2023)
11.4.5 AVADEL PHARMACEUTICALS Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Hypersomnia Drug Introduction
11.5.4 GlaxoSmithKline Revenue in Hypersomnia Drug Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Hypersomnia Drug Introduction
11.6.4 Pfizer Revenue in Hypersomnia Drug Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Theranexus
11.7.1 Theranexus Company Detail
11.7.2 Theranexus Business Overview
11.7.3 Theranexus Hypersomnia Drug Introduction
11.7.4 Theranexus Revenue in Hypersomnia Drug Business (2018-2023)
11.7.5 Theranexus Recent Development
11.8 Fisher & Paykel Healthcare
11.8.1 Fisher & Paykel Healthcare Company Detail
11.8.2 Fisher & Paykel Healthcare Business Overview
11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Introduction
11.8.4 Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2018-2023)
11.8.5 Fisher & Paykel Healthcare Recent Development
11.9 Drive Medical
11.9.1 Drive Medical Company Detail
11.9.2 Drive Medical Business Overview
11.9.3 Drive Medical Hypersomnia Drug Introduction
11.9.4 Drive Medical Revenue in Hypersomnia Drug Business (2018-2023)
11.9.5 Drive Medical Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Hypersomnia Drug Introduction
11.10.4 Merck Revenue in Hypersomnia Drug Business (2018-2023)
11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hypersomnia Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Provigil
Table 3. Key Players of Xyrem
Table 4. Key Players of Others
Table 5. Global Hypersomnia Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Hypersomnia Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Hypersomnia Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Hypersomnia Drug Market Share by Region (2018-2023)
Table 9. Global Hypersomnia Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Hypersomnia Drug Market Share by Region (2024-2029)
Table 11. Hypersomnia Drug Market Trends
Table 12. Hypersomnia Drug Market Drivers
Table 13. Hypersomnia Drug Market Challenges
Table 14. Hypersomnia Drug Market Restraints
Table 15. Global Hypersomnia Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Hypersomnia Drug Market Share by Players (2018-2023)
Table 17. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2022)
Table 18. Ranking of Global Top Hypersomnia Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Hypersomnia Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hypersomnia Drug Product Solution and Service
Table 22. Date of Enter into Hypersomnia Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hypersomnia Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Hypersomnia Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Hypersomnia Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Hypersomnia Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Hypersomnia Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Hypersomnia Drug Revenue Market Share by Application (2018-2023)
Table 30. Global Hypersomnia Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Hypersomnia Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Hypersomnia Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Hypersomnia Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Hypersomnia Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Hypersomnia Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Hypersomnia Drug Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Hypersomnia Drug Market Size by Region (2024-2029) & (US$ Million)
Table 38. Latin America Hypersomnia Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Hypersomnia Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Middle East & Africa Hypersomnia Drug Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Hypersomnia Drug Market Size by Country (2024-2029) & (US$ Million)
Table 42. Teva Company Detail
Table 43. Teva Business Overview
Table 44. Teva Hypersomnia Drug Product
Table 45. Teva Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 46. Teva Recent Development
Table 47. Jazz Pharmaceuticals Company Detail
Table 48. Jazz Pharmaceuticals Business Overview
Table 49. Jazz Pharmaceuticals Hypersomnia Drug Product
Table 50. Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 51. Jazz Pharmaceuticals Recent Development
Table 52. BIOPROJET Company Detail
Table 53. BIOPROJET Business Overview
Table 54. BIOPROJET Hypersomnia Drug Product
Table 55. BIOPROJET Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 56. BIOPROJET Recent Development
Table 57. AVADEL PHARMACEUTICALS Company Detail
Table 58. AVADEL PHARMACEUTICALS Business Overview
Table 59. AVADEL PHARMACEUTICALS Hypersomnia Drug Product
Table 60. AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 61. AVADEL PHARMACEUTICALS Recent Development
Table 62. GlaxoSmithKline Company Detail
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Hypersomnia Drug Product
Table 65. GlaxoSmithKline Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Pfizer Company Detail
Table 68. Pfizer Business Overview
Table 69. Pfizer Hypersomnia Drug Product
Table 70. Pfizer Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Theranexus Company Detail
Table 73. Theranexus Business Overview
Table 74. Theranexus Hypersomnia Drug Product
Table 75. Theranexus Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 76. Theranexus Recent Development
Table 77. Fisher & Paykel Healthcare Company Detail
Table 78. Fisher & Paykel Healthcare Business Overview
Table 79. Fisher & Paykel Healthcare Hypersomnia Drug Product
Table 80. Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 81. Fisher & Paykel Healthcare Recent Development
Table 82. Drive Medical Company Detail
Table 83. Drive Medical Business Overview
Table 84. Drive Medical Hypersomnia Drug Product
Table 85. Drive Medical Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 86. Drive Medical Recent Development
Table 87. Merck Company Detail
Table 88. Merck Business Overview
Table 89. Merck Hypersomnia Drug Product
Table 90. Merck Revenue in Hypersomnia Drug Business (2018-2023) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypersomnia Drug Market Share by Type: 2022 VS 2029
Figure 2. Provigil Features
Figure 3. Xyrem Features
Figure 4. Others Features
Figure 5. Global Hypersomnia Drug Market Share by Application in 2022 & 2029
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Hypersomnia Drug Report Years Considered
Figure 10. Global Hypersomnia Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Hypersomnia Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Hypersomnia Drug Market Share by Region: 2022 VS 2029
Figure 13. Global Hypersomnia Drug Market Share by Players in 2022
Figure 14. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Hypersomnia Drug Revenue in 2022
Figure 16. North America Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Hypersomnia Drug Market Share by Country (2018-2029)
Figure 18. United States Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Hypersomnia Drug Market Share by Country (2018-2029)
Figure 22. Germany Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Hypersomnia Drug Market Share by Region (2018-2029)
Figure 30. China Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Hypersomnia Drug Market Share by Country (2018-2029)
Figure 38. Mexico Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Hypersomnia Drug Market Share by Country (2018-2029)
Figure 42. Turkey Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Hypersomnia Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Teva Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 45. Jazz Pharmaceuticals Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 46. BIOPROJET Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 47. AVADEL PHARMACEUTICALS Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 50. Theranexus Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 51. Fisher & Paykel Healthcare Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 52. Drive Medical Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Hypersomnia Drug Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
